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Abstract
Background: Screening instruments for mental disorders need to be short, engaging, and valid. Current screening
instruments are usually questionnaire-based and may be opaque to the user. A prototype approach where
individuals identify with a description of an individual with typical symptoms of depression, anxiety, social phobia
or panic may be a shorter, faster and more acceptable method for screening. The aim of the study was to evaluate
the accuracy of four new prototype screeners for predicting depression and anxiety disorders and to compare their
performance with existing scales.
Methods: Short and ultra-short prototypes were developed for Major Depressive Disorder (MDD), Generalised
Anxiety Disorder (GAD), Panic Disorder (PD) and Social Phobia (SP). Prototypes were compared to typical short and
ultra-short self-report screening scales, such as the Centre for Epidemiology Scale, CES-D and the GAD-7, and their
short forms. The Mini International Neuropsychiatric Interview (MINI) version 6 [1] was used as the gold standard
for obtaining clinical criteria through a telephone interview. From a population sample, 225 individuals who
endorsed a prototype and 101 who did not were administered the MINI. Receiver operating characteristic (ROC)
curves were plotted for the short and ultra short prototypes and for the short and ultra short screening scales.
Results: The study found that the rates of endorsement of the prototypes were commensurate with prevalence
estimates. The short-form and ultra short scales outperformed the short and ultra short prototypes for every
disorder except GAD, where the GAD prototype outperformed the GAD 7.
Conclusions: The findings suggest that people may be able to self-identify generalised anxiety more accurately
than depression based on a description of a prototypical case. However, levels of identification were lower than
expected. Considerable benefits from this method of screening may ensue if our prototypes can be improved for
Major Depressive Disorder, Social Phobia and Panic Disorder.
Background
Mental health screening tests identify individuals with a
high probability of meeting clinical criteria for a current
mental disorder or those who are at risk of developing
such a disorder. At the population level, screening is
important for targeting treatment and prevention [2],
particularly if it is coupled with multi-modal interven-
tion programs such as collaborative care [3,4]. Recent
meta-analyses show that screening is associated with a
“modest increase in the recognition of depression by
clinicians” ([5], p. 997). Typical screening tools are ques-
tionnaire-based and, ideally short. Most are completed
by the individual rather than the clinician. However,
even short screening tools when used as a battery to
detect a range of multiple conditions can take a long
time to complete. Consequently, researchers are keen to
reduce the length of even the shortest tools while main-
taining or even improving specificity and sensitivity [6].
In addition to being lengthy, screening instruments
can be opaque to the user, boring or baffling, and, thus,
be unacceptable to patients. The acceptability of screen-
ing tests to the public has rarely been examined,
although completion rates of only 30-60% in general
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be a potential problem. Moreover, screening tools may
not work well because individuals may find it difficult to
label emotions or to recognise they have the symptoms
portrayed in many screening items. For example, young
people have poor mental health literacy [7-9], reduced
emotional competency, may lack the “skills to recognise,
interpret and share emotional experiences” ([10], p. 14)
and do not necessarily share a common understanding
of the construct of “depression” which is tapped by cer-
tain depression screeners. In adults, little research exists
which focuses on how individuals view depression and
whether the construct relates to their own symptoms
(see [11] and [12], p. 358), but there is some evidence
that adults in primary care have difficulty differentiating
depression from “reactions to adversity”.
In this study, we sought to develop an alternative
methodology in the hope that it might provide a super-
ior approach to screening. We defined “superior” to
connote a screening tool that retained high sensitivity,
had fast administration time, greater transparency and
that might be rated as more satisfactory by users (easier
to complete and more enjoyable) in comparison to
existing screening tools.
A prototype is the most central or typical member of
a category [13]. Prototypes can be used to represent the
self and others [14-16]. We wondered if prototypes
might serve as a useful means to screen for mental dis-
orders. As a first step in the development of a mental
health prototype, we canvassed the research literature to
see how prototypes have previously been used. Within
mental health, prototype descriptions or typical cases of
mental disorders have been developed to assist clinicians
make diagnoses. This is most clearly demonstrated by
publications such as the DSM-IV Casebooks [17]. How-
ever, a more sophisticated approach based on clinician’s
rating of patients’ characteristics has been developed to
“refine and dimensionalise existing DSM-IV diagnoses
for personality disorder” [18]. In this approach, investi-
gators used a 200 item Q-sort process, where character-
istics of patients were rated as applicable or not, with
items derived from diverse sources including diagnostic
criteria and developmental and personality theories. The
prototypes that were developed received positive feed-
back from clinicians in terms of representing natural
diagnosis patterns. As part of the validation procedure,
clinicians were asked to determine the extent to which a
patient matched or resembled each DSM-IV construct
on a 5 point scale. In this task, clinicians were guided
by the single-sentence summary that introduces each
disorder in the DSM-IV manual ([18], p. 815).
Vignettes (or extended prototypes) [19] have been
used as stimuli to determine whether the public can
correctly label an individual in a vignette as experiencing
a mental disorder such as depression or schizophrenia.
In these studies, the vignette was used to determine
whether the individual could label disorders based on
their description, rather than to test whether they could
identify the symptoms as similar to ones they might
experience themselves. The closest approach to deter-
mining whether prototypes might assist people to iden-
tify their own symptoms arises from work investigating
children’s capacity to identify their own health and wel-
fare, where very young children are asked to identify
with puppet prototypes [20]. The above discussion indi-
cates that prototypes may useful in assisting clinicians
to identify Axis 1 and Axis II disorders, to determine
whether members of the public can name psychiatric
disorders, and to assist children to self identify symp-
toms. These findings indicated that the prototypes
might also be useful as screening tools for adults.
The aim of the present project was to evaluate the use
of a self-administered screening test in which users
match their own thoughts and behaviours to prototypi-
cal descriptions of individuals who are experiencing a
mental disorder. Prototypes were developed against
DSM-IV criteria (see Method). In the interests of devel-
oping very brief screening, ‘ultra short’ prototypes were
also developed by distilling the contents of the prototype
down to one or two sentences. The short and ultra
short prototypes were compared to established brief
screening tools and to their short forms. The Center for
Epidemiological Studies Depression scale (CES-D 20
item, [21]) and a 10-item short-form of this scale [22]
were used to assess depression. The Generalised Anxiety
Disorder (GAD-7) is a seven item screener for general-
ised anxiety disorder [23], with a two-item short-form
[24]. The Panic Disorder Severity Scale - Self Report
( P D S S - S R )i st h es e l f - r e p o r tf o r m[ 2 5 ]o fas c a l et h a t
includes seven descriptive items for measuring the
severity of panic disorder [26]. There are currently no
self-report panic disorder scales with a short form avail-
able, so for the present study, the short form was based
just on the first two items which assess severity and dis-
tress of panic attacks. The Social Phobia Inventory
(SPIN) is a 17-item scale assessing the severity of social
phobia [27], with a three item short form called the
Mini-SPIN [28]. The accuracy with which the prototypes
(short and ultra short) and the screening tests (standard
and short form) identified individuals experiencing each
disorder was assessed using the Mini International Neu-
ropsychiatric Interview (MINI) version 6 [1] as a gold
standard for caseness.
Methods
Participants
Fourteen thousand potential participants were selected
randomly from the Electoral Roll, sampling from two
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Australia. Registration on the Electoral Roll is compul-
sory in Australia. Males and females aged 18-65 were
included in the sample. Surveys were mailed in May
2009, and by the July 2009 cutoff, 2,976 (21.3%) surveys
had been returned. This study received ethics approval
from the Human Research Ethics Committee at the
Australian National University (Protocol 2009/425).
Measures
Demographics
Information was collected on age, gender, educational
level, employment and literacy. Education level was
based on four items assessing previous and current edu-
cational attainment. Employment status was rated as
full-time, part-time and looking for full-time work, part-
time, casual, unemployed - looking for work or not in
the labour force. Literacy was assessed using three
items: language spoken at home, confidence in filling
out forms, and frequency of needing help to read
printed materials.
Prototypes
The measures of interest were short prototypes for
Major Depressive Disorder, Generalised Anxiety Disor-
der (GAD), Panic Disorder and Social Phobia. These are
common mental health disorders that often require clin-
ical intervention and are targets of mental health pre-
vention. The prototypes are presented in additional file
1: Prototype items. An additional prototype for schizo-
phrenia (also presented) was developed to act as a con-
trol, identifying whether respondents endorsed all items
equally or could differentiate between disorders. The
prototypes were created using the DSM-IV-TR diagnos-
tic criteria. For each disorder, all possible symptoms
listed in the criteria were translated into general descrip-
tions that were designed to be comprehensible to the
general adult population. The descriptions were com-
posed into a single, easily-readable paragraph, specifying
symptoms and durations, and personified using a ficti-
tious character. The paragraphs were 74-104 words
each, depending on the number of symptoms that were
required. Respondents were asked to rate how similar
they were to the character in the prototype. Responses
were given on a seven-point Likert scale, with labelled
points at 1, “Not like [name] at all”,4“Like [name]” and
7 “Exactly like [name]”. The Coleman Liau Index was
9.37, and the Flesch Kincaid Grade Level was 7.01 [29].
To keep the prototypes relatively brief, it was not possi-
ble to incorporate exclusion criteria, number of symp-
toms required for diagnosis or subtypes for the
disorders. For symptoms that may be bidirectional (e.g.,
weight increase or decrease), the descriptions were sta-
ted as generalities (e.g., Tom’s weight has changed
recently). The prototype characters were kept as non-
specific as possible to encourage identification - only a
first name (gender) was provided to make the prototype
more understandable. Half of the sample was given the
female versions of the prototypes, with the other half
receiving the male versions.
Ultra short forms of the prototypes for each of the five
disorders were also administered. These are presented in
additional file 2: Ultra short prototype items. These
items were adapted from previous research investigating
mental health literacy [19]. For consistency with their
use in prior research, the short form prototypes were
rated on a five-point Likert scale: “not at all” (1), “a lit-
tle” (2), “some” (3), “a fair bit” (4) or “a lot” (5).
Standardised screening scales
For comparison, standardised scales were also included
in the survey corresponding to each of the disorders
assessed by the prototypes. These were the CES-D, the
GAD-7, Panic Disorder Severity Scale -Self Report and
Social Phobia Inventory (SPIN) and the short forms of
these. The order of presentation of the scales was coun-
terbalanced, so that half of the respondents received the
prototype items followed by the standard scales, while
the other half received the standard scales followed by
the prototypes.
Diagnostic interview
The Mini International Neuropsychiatric Interview
(MINI) version 6 [1] was used as the gold standard for
obtaining clinical criteria for comparing the sensitivity
and specificity of the prototypes to the scales. The MINI
is a brief interview that has strong concordance with
diagnoses based on the Structured Clinical Interview for
DSM-III-R (SCID) or the Composite International Diag-
nostic Interview (CIDI) [30]. Only the modules assessing
depression, social phobia, panic disorder and generalised
anxiety disorder (GAD) were administered, correspond-
ing to each of the prototypes being assessed. Exclusion
criteria including drug use, medication use and alterna-
tive diagnosis (for GAD) were not assessed, to maintain
comparability to the prototypes and scales used in the
survey.
Procedure
Surveys included the short and the ultra short versions
of the prototypes, the four standard scales and their
short forms (CES-D, GAD-7, SPIN and PDSS-SR), ques-
tions on background characteristics, and a consent form
for clinical interview. These surveys were mailed to the
14,000 potential participants, along with information
about the study. A subsample of respondents was then
selected for a clinical interview. An algorithm for clinical
interview selection was designed prior to the study, aim-
ing to administer clinical interviews with all of the
respondents with high scores on the prototypes and
some of the participants with low scores according to a
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who did not identify with any of the prototypes was also
selected for interview. Only participants who provided a
telephone number and consented to be interviewed
were contacted. Participants who identified at any level
with the schizophrenia prototype (n = 64) were excluded
from having a phone interview.
The clinical interviews (MINI) were conducted over
the telephone by a team of four clinical psychology post-
graduate students and one trainee clinical psychologist,
all of whom received three hours of training in the
administration of the clinical interview, including a
videoconference with the authors of the MINI. From the
2,976 respondents, 1,257 consented and were eligible for
a clinical interview. A total of 349 participants who
endorsed a prototype and 129 who did not endorse a
prototype were selected for clinical interviews. Of those
selected, interviews were completed with 225 endorsers
(64.5%) and 101 non-endorsers (78.3%). Up to seven call
attempts were made in order to contact each of
the selected participants, with a two-week window given
to make contact after the survey was returned. Clinical
interviewers were blinded to the survey responses of
the interviewees. The sampling procedure is shown in
Figure 1.
Analyses
Prototype responses were examined across the five dis-
orders, and compared to population rates of caseness.
Receiver operating characteristic (ROC) curves were
plotted for the prototypes, ultra short prototypes, scales
and short-form scales, comparing criteria for caseness
on each of these measures to clinical caseness based on
the MINI. The critical test of the effectiveness each pro-
totype as a screening tool was to assess whether the
area under the short and ultra short prototype ROC
curve was as large as the area under the versions of the
standard scales and their short forms. Cutoffs for each
prototype were established using Youden indices to
maximise sensitivity and specificity. The sensitivity and
specificity of these cutoffs were compared to the sensi-
tivity and specificity of the scales and short-form scales
using their established cutoffs c o r e s .R e s p o n d e n t sw i t h
missing responses on a prototype or scale, or an incom-
plete module of the MINI were excluded from the com-
parison for that particular disorder only, resulting in
analysis samples of 322 for depression, 324 for GAD,
324 for social phobia and the complete sample of 326
for panic disorder.
Results
The flow of participants in the trial is shown in Figure
1. The 14,000 people who received the survey were
51.1% female. However, females had a higher response
rate to the survey (60.7% of respondents were female).
Consequently more clinical interviews were conducted
with females (63.5% of interviewees were female),
although interviewing rates were not significantly differ-
ent between female and male respondents [11.4% of
female respondents were interviewed vs. 10.3% males, c
2
(2) = 2.2, p = .332]. The age distributions of respondents
to the survey and respondents to the clinical interview
were also not significantly different [c
2 (5) = 5.4, p =
.371]. While efforts were made to select a representative
sample, representativeness is not critical for the pur-
poses of comparing multiple measures. The participants
who completed a clinical interview were well educated
(mean = 14.7 y, SD = 2.4 y), with the majority in full-
time (n = 156, 47.9%) or part-time (n = 72, 22.1%)
employment. Almost all respondents to the clinical
interview spoke exclusively English at home (n = 308,
94.5%) and very few relied on assistance for completing
forms (n = 24; 7.4%) or for reading printed materials (n
= 15; 4.6%).
Rates of prototype endorsement across the survey
sample (n = 2,976) are shown in Figure 2. As category 1
represented no identification with the prototype, this
category is not visible in the figure, such that the
remainder of respondents (63.4%-97.8%) did not identify
at all with the respective prototypes. The percentages
listed in the figure represent the percentage of endorse-
ments across all levels from 2-7. A method to assess
whether the rates of endorsements was comparable with
rates in the general population is to take the rate of
clinical caseness (based on the MINI) for each level of
prototype endorsement among the 326 clinical intervie-
wees and project these rates across the entire survey
sample. Using this method, the base rate of depression
in the sample was 6.9%, 5.0% for GAD, 1.7% for social
14,000 surveys sent
2,976 completed surveys 
returned (8 July 2009)
1,257 consented & eligible for 
phone interview (MINI)
616 endorsed one or 
more prototypes
641 did not endorse a 
prototype
349 selected for MINI 
clinical interview
129 selected for MINI 
clinical interview
225 MINI interviews 
completed
101 MINI interviews 
completed 
326 MINI interviews completed
21%
42%
49% 51%
57% 20%
78% 64%
Figure 1 Sampling procedure and response rates.
Christensen et al. BMC Medical Research Methodology 2011, 11:154
http://www.biomedcentral.com/1471-2288/11/154
Page 4 of 9phobia and 1.4% for panic disorder. These base rate esti-
mates, along with the raw prototype endorsement rates,
were not dissimilar to the rates of these disorders in the
general population: 4.1% for depression, 2.7% for GAD,
4.7% for social phobia and 2.6% for panic disorder [31].
Overall, 51.3% of survey respondents endorsed none of
the four prototypes, 20.6% endorsed one prototype at
any level (i.e., a rating of 2 or higher), 14.1% endorsed
two prototypes and 13.8% endorsed three or four of the
prototypes.
The prototypes, ultra short prototypes, scales and
short-form scales were compared to MINI criteria using
ROC curves, displayed in Figure 3. The MINI identified
33 participants as meeting criteria for GAD and 32 for
depression, but only nine for social phobia and six for
panic disorder. As is evident from the ROC plots, the
scales and short-form scales outperformed the short and
ultra short prototypes for every disorder except GAD.
Although the AUC confidence intervals of the proto-
types overlapped with those of the short-form scales for
all of the disorders, the ROC curves suggest that the
short form scales performed better than the depression,
social phobia and panic prototypes at the assessed cut
points. For the GAD prototype, the area under the
curve was 0.87, compared to 0.83 for the scale (GAD-7)
and 0.81 for the short-form scale (GAD-2). None of the
ultra short prototypes was an adequate screener for any
of the disorders, as the lower limit of the AUC confi-
dence intervals approached or were below 0.5 and the
sensitivity-specificity combinations at the cut points
were poor. Results for social phobia and panic disorder
may be uncertain, due to the paucity of cases in the
sample.
Based on Youden indices to maximise sensitivity and
specificity, cutoffs were established for each of the pro-
totypes and ultra short prototypes. For depression and
panic disorder, the cut-off that maximised the trade-off
between sensitivity and specificity was 2, while for GAD
and social phobia it was a score of 3. For the ultra short
prototypes, a cut-off of 2 was selected. Sensitivity and
specificity for each of these measures, along with the
standard scales and short-form standard scales, is shown
in Table 1. The cut-offs used for the scales were based
on previously established criteria: ≥ 16 for the CES-D
[21], ≥ 8 for the CES-D short form [22], ≥ 10 for the
GAD-7 [23], ≥ 3 for the GAD-2 [24], ≥ 19 for the SPIN
[27], ≥ 6 for the Mini-SPIN [28], ≥ 8f o rt h eP D S S - S R
[32], and ≥ 4 for the first two items of the PDSS-SR,
corresponding to two or more attacks and moderate or
greater distress. The depression prototype had good sen-
sitivity using the cut-off of 2; however, the specificity
was poor. Using a cut-off of 3, the GAD prototype had
0%
5%
10%
15%
20%
25%
30%
35%
40%
GAD Depression Social phobia Panic disorder Schizophrenia
1 - Not at all like me
2
3
4 - Like me
5
6
7 - Exactly like me
36.6%
25.0% 24.5%
9.3%
2.2%
Figure 2 Rates of prototype endorsement.
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ficity compared to both the full standard scale and the
short-form scale. The social phobia prototype performed
as well as the Mini-SPIN using a cut-off of 3 (or 77.8%
sensitivity 67.3% specificity with a cut-off of 2), while
the panic disorder prototype was clearly outperformed
by the PDSS-SR, although very few respondents met the
clinical criteria for these two disorders.
Discussion
Summary
T h ec o r ef i n d i n go ft h ep r e s e n ts t u d yi st h a ti ng e n -
eral, the prototypes did not perform better than the
standard screening tools. Indeed, although the scales
and prototypes had overlapping confidence intervals, it
appeared that the scales and short-form scales outper-
formed the short and ultra short prototypes for every
disorder except GAD. With respect to GAD, the find-
ings suggest that people can self-identify generalised
anxiety better than other disorders based on a descrip-
tion of a prototypical case. The reason the GAD proto-
types performed as well or better than the screener is
unclear. The superiority of the screening scales over
the depression prototype may arise because depression
symptoms are heterogeneous, or it may be due to the
fact that depression modifies people’sp e r c e p t i o n so f
symptoms. It may also be due to the relative positive
compared to a negative symptom profile associated
Figure 3 ROC curves for the prototypes, short-form prototypes, scales and short-form scales for depression, GAD, social phobia and
panic disorder.
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anxiety is associated with fast heartbeat and sweating.
Depression is associated with reduced energy, lower
mood, and slower activities. The fact that the GAD
prototype was superior or at least as good as the
GAD-7 scale suggests that self identification of mental
health symptoms is possible. Nevertheless, based on
the data collected to date, conventional screening tests
are generally more useful than our prototypes for all
disorders with the exception of GAD. Because of the
small numbers in the social phobia and panic cate-
gories, replication of these findings in a larger sample
is required.
The study found that the rates of endorsement of the
prototypes were commensurate with prevalence esti-
mates, although the rates appeared to be lower for social
phobia. Differences in rates between the prototypes and
population estimates may be explained by the non-
exclusion of other anxiety disorders from GAD caseness
in our study, the predictive merits of the prototypes and
differing response rates in the community across the
disorders. For social phobia, for example, fewer indivi-
duals with social phobia may have agreed to the study,
or the prototype might have been too strictly limited in
symptoms. In addition, the rates of endorsement of the
prototypes displayed reasonably good correspondence
with existing scales.
Comparisons to other screening tools
Although most prototypes were not superior to those of
the brief screening scales, their performance as screen-
ing tools was generally respectable, with sensitivity >
75% at specific cutoffs for the GAD and depression pro-
totypes. Data suggests that standardised questionnaires
to detect depression have a median sensitivity of 75%
[3]. In general practice settings, researchers have found
that single item tests had an overall sensitivity of 31.9%
and specificity of 96.0% [33]. Pooled analysis of two or
three item tests, found sensitivity of 73.7% and specifi-
city of 74.7%. Like most screening tools, these data sug-
gest that the prototypes may be useful for ruling out
depression or anxiety, although not so useful for identi-
fying depression or anxiety levels likely to meet criteria
to be a case.
Limitations of the study
There were insufficient cases of Social Phobia or Panic
Disorder to evaluate the protocols for this study - these
will need to be further assessed in a future study. The
time frame for symptom duration was different across
the scales, and this may have affected differences in spe-
cificity and sensitivity. We did not measure acceptability
of the prototypes or the standard scales. It may be that
prototypical screening tools have the advantage that
they provide a positive learning experience for the user,
Table 1 Sensitivity and specificity (95% confidence intervals) for prototypes and scales at designated cut-offs
Measure Criterion Sensitivity (95% CI) Specificity (95% CI) AUC (95%CI)
Depression
Full Scale (CES-D) ≥ 16 87.5% (71.0% - 96.5%) 72.4% (66.9% - 77.5%) 0.86 (0.81 - 0.92)
Short form scale (CES-D SF) ≥ 8 84.4% (67.2% - 94.7%) 69.7% (64.0% - 74.9%) 0.84 (0.78 - 0.90)
Depression prototype ≥ 2 81.3% (63.6% - 92.8%) 59.0% (53.1% - 64.7%) 0.73 (0.64 - 0.82)
Depression short prototype ≥ 2 50.0% (31.9% - 68.1%) 75.5% (70.2% - 80.4%) 0.64 (0.54 - 0.73)
Generalised Anxiety Disorder
Full Scale (GAD-7) ≥ 10 60.6% (42.1% - 77.1%) 87.6% (83.3% - 91.1%) 0.83 (0.76 - 0.90)
Short form scale (GAD-2) ≥ 3 57.6% (39.2% - 74.5%) 86.3% (81.8% - 90.0%) 0.81 (0.73 - 0.89)
GAD prototype ≥ 3 90.9% (75.7% - 98.1%) 72.1% (66.5% - 77.2%) 0.87 (0.83 - 0.92)
GAD short prototype ≥ 2 75.8% (57.7% - 88.9%) 66.0% (60.2% - 71.4%) 0.74 (0.65 - 0.83)
Social phobia
Full Scale (SPIN) ≥ 19 88.9% (51.8% - 99.7%) 81.3% (76.6% - 85.5%) 0.92 (0.83 - 1.00)
Short form scale (Mini-SPIN) ≥ 6 66.7% (29.9% - 92.5%) 85.8% (81.4% - 89.4%) 0.90 (0.81 - 0.99)
Social phobia prototype ≥ 3 66.7% (29.9% - 92.5%) 86.7% (82.4% - 90.2%) 0.81 (0.63 - 0.99)
Social phobia short prototype ≥ 2 33.3% (7.5% - 70.1%) 84.8% (80.3% - 88.6%) 0.59 (0.43 - 0.76)
Panic disorder
Full Scale (PDSS-SR) ≥ 8 66.7% (22.3% - 95.7%) 95.6% (92.8% - 97.6%) 0.87 (0.69 - 1.00)
Short form scale (PDSS-SR items 1 & 2) ≥ 4 66.7% (22.3% - 95.7%) 90.3% (86.5% - 93.3%) 0.88 (0.69 - 1.00)
Panic disorder prototype ≥ 2 50.0% (11.8% - 88.2%) 81.3% (76.5% - 85.4%) 0.67 (0.44 - 0.91)
Panic disorder short prototype ≥ 2 83.3% (35.9% - 99.6%) 51.9% (46.3% - 57.5%) 0.73 (0.51 - 0.95)
Note: AUC: Area under the curve; CES-D: Center for Epidemiological Studies Depression scale; GAD: Generalised Anxiety Disorder; SPIN: Social Phobia Inventory;
PDSS-SR: Panic Disorder Severity Scale - Self Report.
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to seek help, or are associated with higher acceptability.
However these factors, along with additional measures
of validity and reliability, were not measured in this
study, and are the target of ongoing research. Although
the response rate of 21% is consistent with other mail-
based community surveys, the sample may have been
prone to a number of selection biases. The sample was
well educated and most were highly literate in English,
and it is possible that different outcomes may have
arisen if the sample was less well educated. Whether the
prototypes might perform better in a less well educated
sample requires further research. Nevertheless, the pri-
mary aim of the study was to compare the accuracy of
responses on two scales (the prototypes vs. standard
scales), so representativeness does not diminish this
within-person comparison. An additional limitation of
the study is that the gold standard employed to detect
“caseness” used non-exclusion based diagnosis, and did
not attempt differential diagnosis. As such, the use of
non-exclusion based diagnosis as the core gold standard
will produce different prevalence rates than those based
on differential diagnosis. For example, the National
Comorbidity Survey reported prevalence estimates with
exclusions for the DSM-III-R hierarchical rules [34].
Nevertheless, the methodology used in the present study
is commonly applied when large population studies are
undertaken. Importantly, however, this methodological
limitation does not compromise the aim of the study,
which is to compare two methodologies to the same
“gold standard” diagnosis.
Further research
Further research is needed to test the anxiety prototype
and to investigate whether the depression prototype
might be improved. It is not clear whether prototypes
are accurate screening tools for particular individuals,
and we are currently investigating predictors, such as
previous depression history, to determine for whom the
prototypes might be useful. We will also investigate
symptoms that are most strongly associated with proto-
type endorsement and to refine prototype descriptions.
We also plan to investigate satisfaction and ease of use
[3] for the GAD prototype, and to test the prototypes in
clinical populations where their performance requires
evaluation.
Conclusions
We were motivated to develop a new method of screen-
ing for a number of reasons, including ease of use and
satisfaction for users. Without further refinement, the
evidence suggests that, with the exception of GAD,
screening for mental health problems at this stage is
superior if short screening tools are used.
Additional material
Additional file 1: Prototype Items. The prototype measures used in the
present study.
Additional file 2: Ultra short prototype items. The ultra short
prototype measures used in the present study.
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